Why did HRZN's board increase the buyback authorization?

The board authorized the increase on August 3, 2026, bringing total capacity to $20 million (up from $10 million), signaling confidence that shares trading around $4.54 represent good value versus the company's $6.23 NAV per share. The expansion allows management to repurchase more shares at a substantial discount if market conditions remain favorable.

How much has HRZN repurchased to date under this program?

From inception through June 30, 2026, HRZN repurchased 1,532,687 shares at an average price of $5.27 per share for $8.1 million total. In Q2 2026 alone, the company bought back 1,365,222 shares at $4.54 per share for $6.2 million, capturing a 27% discount to NAV.

What constraints apply to HRZN's buyback program?

Shares may only be repurchased when trading below 90% of the most recently disclosed NAV, at prices below the reported NAV, and aggregate purchases cannot exceed 2% of shares outstanding at the time of purchase. The program was extended through June 30, 2027 on May 1, 2026.

How does the discount to NAV make buybacks accretive to shareholders?

When HRZN retires shares bought at $4.54 versus NAV of $6.23, the remaining share count declines while net assets stay constant, mathematically increasing NAV per share for continuing shareholders—a form of internal value creation regardless of future portfolio performance.

What is HRZN's business model and why does it focus on buybacks?

HRZN is a business development company providing secured venture debt to growth companies in tech, life sciences, and healthcare. BDCs often return capital to shareholders through distributions and opportunistic buybacks when shares trade below NAV, as NAV is the primary metric of intrinsic value.

Does the $20M authorization represent all remaining capacity?

The August 3, 2026 authorization sets the total buyback capacity at $20 million. With $8.1 million deployed through June 30, 2026, approximately $11.9 million remains available under the current authorization, subject to the 2% per-purchase limit and NAV-based pricing restrictions.

HTFC 8-K Filed 2026-08-04 Amendment

Horizon Technology Finance expands buyback program to $20M

Board increases repurchase authorization by $10M on August 3, 2026; company has bought back $8.1M to date.

MechanismRule 10b-18 open-market purcha

What the filing says

Horizon Technology Finance Corporation (NASDAQ: HRZN) announced on August 3, 2026, that its board of directors approved an increase in the amount of common stock that may be repurchased under the company's stock repurchase program to allow purchases of up to a total of $20 million of common stock, up from the previous authorization of $10 million.

The expansion comes as the company reported second-quarter 2026 results including significant repurchase activity during the quarter. During the three months ended June 30, 2026, HRZN repurchased 1,365,222 shares at an average price of $4.54 per share for a total cost of $6.2 million. From the inception of the stock repurchase program through June 30, 2026, the company had repurchased a cumulative 1,532,687 shares at an average price of $5.27 per share for a total cost of $8.1 million.

Under the terms of the program, which was extended through June 30, 2027 on May 1, 2026, the company may repurchase shares at prices below net asset value per share, provided such purchases do not exceed 2% of shares outstanding at the time of purchase and shares are traded below 90% of the most recently disclosed NAV per share. As of June 30, 2026, Horizon's net asset value was $6.23 per share.

On August 3, 2026, the Company's board of directors approved an increase in the amount of common stock that may be repurchased under the stock repurchase program to allow the Company to repurchase up to a total of $20 million of common stock. — Horizon Technology Finance Corp 8-K filing · View on SEC EDGAR →

What this means

The $10 million increase in authorization reflects management's confidence that HRZN shares are trading below intrinsic value. The company repurchased shares at $4.54 in Q2 2026, substantially below the NAV of $6.23 per share reported at quarter-end, capturing a discount of approximately 27%. This accretive repurchase activity benefits remaining shareholders by retiring cheaper shares. The amendment brings total authorization to $20 million, with $8.1 million deployed since program inception, leaving approximately $11.9 million available for future purchases before this authorization. The 2% share-count limit ensures buyback activity does not become outsized relative to the public float.

Frequently asked questions

Why did HRZN's board increase the buyback authorization?: The board authorized the increase on August 3, 2026, bringing total capacity to $20 million (up from $10 million), signaling confidence that shares trading around $4.54 represent good value versus the company's $6.23 NAV per share. The expansion allows management to repurchase more shares at a substantial discount if market conditions remain favorable.
How much has HRZN repurchased to date under this program?: From inception through June 30, 2026, HRZN repurchased 1,532,687 shares at an average price of $5.27 per share for $8.1 million total. In Q2 2026 alone, the company bought back 1,365,222 shares at $4.54 per share for $6.2 million, capturing a 27% discount to NAV.
What constraints apply to HRZN's buyback program?: Shares may only be repurchased when trading below 90% of the most recently disclosed NAV, at prices below the reported NAV, and aggregate purchases cannot exceed 2% of shares outstanding at the time of purchase. The program was extended through June 30, 2027 on May 1, 2026.
How does the discount to NAV make buybacks accretive to shareholders?: When HRZN retires shares bought at $4.54 versus NAV of $6.23, the remaining share count declines while net assets stay constant, mathematically increasing NAV per share for continuing shareholders—a form of internal value creation regardless of future portfolio performance.
What is HRZN's business model and why does it focus on buybacks?: HRZN is a business development company providing secured venture debt to growth companies in tech, life sciences, and healthcare. BDCs often return capital to shareholders through distributions and opportunistic buybacks when shares trade below NAV, as NAV is the primary metric of intrinsic value.
Does the $20M authorization represent all remaining capacity?: The August 3, 2026 authorization sets the total buyback capacity at $20 million. With $8.1 million deployed through June 30, 2026, approximately $11.9 million remains available under the current authorization, subject to the 2% per-purchase limit and NAV-based pricing restrictions.

amendment bdc open-market 10b-18 nav-discount execution

Source. This editorial summary is based on the SEC filing linked above. BuybackStocks aggregates and editorializes publicly available SEC EDGAR filings. Not investment advice. Past authorization announcements do not guarantee future repurchase activity or share price performance. See our full disclosures policy.